Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea-Reference-Cited by-同舟云学术

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea

Published:2017-04-15 Issue:2 Volume:49 Page:454-463
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Beom Seung Hoon,Oh Jisu,Kim Tae-Yong,Lee Kyung-Hun,Yang Yaewon,Suh Koung Jin,Moon Hyeong-Gon,Han Sae-Won,Oh Do-Youn,Han Wonshik,Kim Tae-You,Noh Dong-Young,Im Seock-Ah

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Seoul National University College of Medicine

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-2016-259.pdf

Reference18 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Prediction of Cancer Incidence and Mortality in Korea, 2013

3. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer

4. Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group

5. Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis;Gynecologic Oncology;2017-10